Valuation Update With 7 Day Price Move • May 12
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥65.99, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 246% over the past three years. Price Target Changed • Apr 26
Price target increased by 11% to CN¥56.68 Up from CN¥50.89, the current price target is an average from 3 analysts. New target price is 7.9% above last closing price of CN¥52.52. Stock is up 266% over the past year. The company is forecast to post earnings per share of CN¥1.46 for next year compared to CN¥1.08 last year. Reported Earnings • Apr 25
First quarter 2026 earnings: EPS and revenues exceed analyst expectations First quarter 2026 results: EPS: CN¥0.30 (up from CN¥0.22 in 1Q 2025). Revenue: CN¥6.85b (up 25% from 1Q 2025). Net income: CN¥507.5m (up 40% from 1Q 2025). Profit margin: 7.4% (up from 6.6% in 1Q 2025). Revenue exceeded analyst estimates by 16%. Earnings per share (EPS) also surpassed analyst estimates by 12%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings. New Risk • Apr 13
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks High level of debt (49% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to CN¥50.14, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years. Ankündigung • Mar 31
Sinoma Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 New Risk • Mar 23
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 41% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.6% average weekly change). Large one-off items impacting financial results. Reported Earnings • Mar 20
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: CN¥1.08 (up from CN¥0.53 in FY 2024). Revenue: CN¥30.2b (up 26% from FY 2024). Net income: CN¥1.82b (up 104% from FY 2024). Profit margin: 6.0% (up from 3.7% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.3%. Revenue is forecast to grow 9.0% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Ankündigung • Mar 19
Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026 Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026, at 16:30 China Standard Time. Location: 12F, Building 7, Yard No. 6, North Street, Dongsheng Science and Technology Park, Haidian District, Beijing China Price Target Changed • Feb 14
Price target increased by 17% to CN¥43.36 Up from CN¥37.11, the current price target is an average from 3 analysts. New target price is 9.3% below last closing price of CN¥47.81. Stock is up 286% over the past year. The company is forecast to post earnings per share of CN¥1.12 for next year compared to CN¥0.53 last year. New Risk • Feb 12
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.9% average weekly change). Minor Risks High level of debt (48% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to CN¥49.87, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 129% over the past three years. Ankündigung • Dec 31
Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 20, 2026 Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 20, 2026 Valuation Update With 7 Day Price Move • Dec 25
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥39.57, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 100% over the past three years. Valuation Update With 7 Day Price Move • Oct 30
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥35.33, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 111% over the past three years. Reported Earnings • Oct 22
Third quarter 2025 earnings released: EPS: CN¥0.29 (vs CN¥0.086 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.29 (up from CN¥0.086 in 3Q 2024). Revenue: CN¥8.37b (up 34% from 3Q 2024). Net income: CN¥481.1m (up 235% from 3Q 2024). Profit margin: 5.7% (up from 2.3% in 3Q 2024). Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Price Target Changed • Sep 24
Price target increased by 39% to CN¥36.87 Up from CN¥26.50, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of CN¥35.55. Stock is up 249% over the past year. The company is forecast to post earnings per share of CN¥1.23 for next year compared to CN¥0.53 last year. Valuation Update With 7 Day Price Move • Sep 04
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥31.05, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years. New Risk • Sep 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.7% average weekly change). Minor Risks High level of debt (52% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Reported Earnings • Aug 24
Second quarter 2025 earnings released: EPS: CN¥0.38 (vs CN¥0.15 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.38 (up from CN¥0.15 in 2Q 2024). Revenue: CN¥7.83b (up 28% from 2Q 2024). Net income: CN¥636.6m (up 155% from 2Q 2024). Profit margin: 8.1% (up from 4.1% in 2Q 2024). Revenue is forecast to grow 8.8% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥32.00, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 34% over the past three years. New Risk • Jul 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin). Valuation Update With 7 Day Price Move • Jul 21
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥28.44, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 12% over the past three years. Price Target Changed • Jul 13
Price target increased by 21% to CN¥20.69 Up from CN¥17.09, the current price target is an average from 4 analysts. New target price is 13% below last closing price of CN¥23.76. Stock is up 109% over the past year. The company is forecast to post earnings per share of CN¥1.02 for next year compared to CN¥0.53 last year. Ankündigung • Jul 02
Sinoma Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 22, 2025 Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 22, 2025 Price Target Changed • Jul 01
Price target increased by 12% to CN¥18.26 Up from CN¥16.34, the current price target is an average from 4 analysts. New target price is 15% below last closing price of CN¥21.45. Stock is up 68% over the past year. The company is forecast to post earnings per share of CN¥0.99 for next year compared to CN¥0.53 last year. Valuation Update With 7 Day Price Move • Jul 01
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥21.45, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 22x in the Chemicals industry in China. Total loss to shareholders of 16% over the past three years. Declared Dividend • May 25
Dividend reduced to CN¥0.23 Dividend of CN¥0.23 is 60% lower than last year. Ex-date: 30th May 2025 Payment date: 30th May 2025 Dividend yield will be 1.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (27% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 103% over the next 3 years, which should provide support to the dividend and adequate earnings cover. New Risk • Apr 26
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.8x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin). Reported Earnings • Apr 24
First quarter 2025 earnings released: EPS: CN¥0.22 (vs CN¥0.13 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.22 (up from CN¥0.13 in 1Q 2024). Revenue: CN¥5.51b (up 24% from 1Q 2024). Net income: CN¥362.1m (up 68% from 1Q 2024). Profit margin: 6.6% (up from 4.9% in 1Q 2024). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥13.02, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥21.11 per share. Ankündigung • Mar 31
Sinoma Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 24, 2025 Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025 Price Target Changed • Mar 28
Price target increased by 12% to CN¥17.09 Up from CN¥15.27, the current price target is an average from 4 analysts. New target price is 16% above last closing price of CN¥14.73. Stock is down 4.3% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥0.53 last year. Major Estimate Revision • Mar 26
Consensus EPS estimates increase by 12% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from CN¥27.7b to CN¥28.9b. EPS estimate increased from CN¥0.845 to CN¥0.95 per share. Net income forecast to grow 78% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥15.27 to CN¥16.34. Share price was steady at CN¥14.76 over the past week. New Risk • Mar 22
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.9x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.7% net profit margin). Price Target Changed • Mar 20
Price target increased by 14% to CN¥16.35 Up from CN¥14.31, the current price target is an average from 5 analysts. New target price is 11% above last closing price of CN¥14.78. Stock is down 3.8% over the past year. The company is forecast to post earnings per share of CN¥0.95 for next year compared to CN¥0.53 last year. Reported Earnings • Mar 20
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: CN¥0.53 (down from CN¥1.33 in FY 2023). Revenue: CN¥24.0b (down 7.4% from FY 2023). Net income: CN¥891.9m (down 60% from FY 2023). Profit margin: 3.7% (down from 8.6% in FY 2023). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 12%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Ankündigung • Mar 20
Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025 Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025, at 16:30 China Standard Time. Location: The Company's Meeting Room, Beijing China Valuation Update With 7 Day Price Move • Feb 24
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥14.66, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 46% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.31 per share. Price Target Changed • Jan 07
Price target increased by 9.9% to CN¥13.55 Up from CN¥12.33, the current price target is an average from 5 analysts. New target price is 8.0% above last closing price of CN¥12.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of CN¥0.67 for next year compared to CN¥1.33 last year. Ankündigung • Dec 31
Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 20, 2025 Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 20, 2025 Major Estimate Revision • Nov 20
Consensus EPS estimates increase by 11% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from CN¥0.625 to CN¥0.691. Revenue forecast steady at CN¥23.9b. Net income forecast to grow 40% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target up from CN¥12.33 to CN¥12.83. Share price fell 6.1% to CN¥13.30 over the past week. Ankündigung • Nov 15
Sinoma Science & Technology Co.,Ltd. Appoints Feng Jun as Director Sinoma Science & Technology Co.,Ltd. held its 4th Extraordinary General Meeting of 2024 on 13 November 2024 were approved; Election of Feng Jun as a director. Reported Earnings • Oct 26
Third quarter 2024 earnings released: EPS: CN¥0.086 (vs CN¥0.19 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.086 (down from CN¥0.19 in 3Q 2023). Revenue: CN¥6.27b (up 7.1% from 3Q 2023). Net income: CN¥143.7m (down 55% from 3Q 2023). Profit margin: 2.3% (down from 5.4% in 3Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year whereas the company’s share price has fallen by 30% per year. Ankündigung • Sep 30
Sinoma Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥11.61, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 64% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥8.71 per share. Buy Or Sell Opportunity • Sep 26
Now 24% overvalued Over the last 90 days, the stock has fallen 16% to CN¥10.86. The fair value is estimated to be CN¥8.73, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.7% over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 35% in 2 years. Earnings are forecast to grow by 70% in the next 2 years. Ankündigung • Sep 11
Sinoma Science & Technology Co.,Ltd. Approves Board Elections Sinoma Science & Technology Co.,Ltd. at its EGM held on September 9, 2024 approved election of Zhuang Qinxia as director and Wang Guanyu as independent director. Major Estimate Revision • Aug 28
Consensus revenue estimates fall by 14% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥28.7b to CN¥24.7b. EPS estimate fell from CN¥1.38 to CN¥0.79 per share. Net income forecast to grow 27% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥17.92 to CN¥11.69. Share price fell 2.5% to CN¥9.68 over the past week. Reported Earnings • Aug 22
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: EPS: CN¥0.15 (down from CN¥0.58 in 2Q 2023). Revenue: CN¥6.11b (down 17% from 2Q 2023). Net income: CN¥248.4m (down 75% from 2Q 2023). Profit margin: 4.1% (down from 13% in 2Q 2023). Revenue missed analyst estimates by 32%. Earnings per share (EPS) also missed analyst estimates by 62%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings. Major Estimate Revision • Aug 09
Consensus EPS estimates fall by 14% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥29.1b to CN¥28.7b. EPS estimate also fell from CN¥1.61 per share to CN¥1.38 per share. Net income forecast to grow 21% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥22.58 to CN¥17.92. Share price was steady at CN¥11.11 over the past week. Price Target Changed • Aug 06
Price target decreased by 20% to CN¥17.92 Down from CN¥22.52, the current price target is an average from 4 analysts. New target price is 60% above last closing price of CN¥11.22. Stock is down 50% over the past year. The company is forecast to post earnings per share of CN¥1.51 for next year compared to CN¥1.33 last year. Ankündigung • Jun 29
Sinoma Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 22, 2024 Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 22, 2024 Declared Dividend • May 27
Dividend reduced to CN¥0.56 Dividend of CN¥0.56 is 15% lower than last year. Ex-date: 31st May 2024 Payment date: 31st May 2024 Dividend yield will be 3.6%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 28% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 66% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Ankündigung • May 26
Sinoma Science & Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024 Sinoma Science & Technology Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.60000000. Record date: 30 May 2024; Ex-date: 31 May 2024; Payment date: 31 May 2024. Ankündigung • May 15
Sinoma Science & Technology Co.,Ltd. Elects Zhang Wenjin as a Director Sinoma Science & Technology Co.,Ltd. held its first Extraordinary General Meeting of 2024 on 13 May 2024, elected Zhang Wenjin as a director. Major Estimate Revision • May 07
Consensus EPS estimates increase by 15% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from CN¥1.49 to CN¥1.71. Revenue forecast unchanged at CN¥29.7b. Net income forecast to grow 45% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target of CN¥23.26 unchanged from last update. Share price rose 7.3% to CN¥16.66 over the past week. Reported Earnings • Apr 26
First quarter 2024 earnings: EPS and revenues miss analyst expectations First quarter 2024 results: EPS: CN¥0.13 (down from CN¥0.25 in 1Q 2023). Revenue: CN¥4.43b (up 4.1% from 1Q 2023). Net income: CN¥216.2m (down 48% from 1Q 2023). Profit margin: 4.9% (down from 9.8% in 1Q 2023). Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 58%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 11% per year. Ankündigung • Mar 30
Sinoma Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Major Estimate Revision • Mar 28
Consensus EPS estimates fall by 27% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥30.1b to CN¥28.8b. EPS estimate also fell from CN¥2.04 per share to CN¥1.48 per share. Net income forecast to grow 12% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target down from CN¥27.21 to CN¥22.52. Share price was steady at CN¥15.08 over the past week. Ankündigung • Mar 23
Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024 Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Agenda: To consider 2023 annual report and its summary; to consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider 2024 estimated continuing connected transactions; to consider Amendments to the system for independent directors; to consider Amendments to the Company's articles of association; to consider 2024 loan budget and authorization for relevant loans; to consider Application for registration and issuance of not more than CNY 4.8 billion super and short-term commercial papers at a proper time; to consider Application for registration and issuance of not more than CNY 0.9 billion commercial papers; to consider Reappointment of 2024 audit firm; to consider Election of Wang Li as a supervisor. New Risk • Mar 23
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 22% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (43% net debt to equity). Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (8.6% net profit margin). Price Target Changed • Mar 22
Price target decreased by 11% to CN¥25.94 Down from CN¥29.11, the current price target is an average from 5 analysts. New target price is 70% above last closing price of CN¥15.27. Stock is down 39% over the past year. The company is forecast to post earnings per share of CN¥1.49 for next year compared to CN¥1.33 last year. Reported Earnings • Mar 22
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2023 results: EPS: CN¥1.33 (down from CN¥2.09 in FY 2022). Revenue: CN¥25.9b (up 17% from FY 2022). Net income: CN¥2.22b (down 37% from FY 2022). Profit margin: 8.6% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) missed analyst estimates by 15%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Feb 06
Now 29% overvalued Over the last 90 days, the stock has fallen 21% to CN¥13.94. The fair value is estimated to be CN¥10.77, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has grown by 11%. Revenue is forecast to grow by 49% in 2 years. Earnings are forecast to grow by 46% in the next 2 years. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥12.68, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.87 per share. Ankündigung • Dec 30
Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024 Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024 Major Estimate Revision • Oct 30
Consensus EPS estimates fall by 33% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥26.2b to CN¥25.7b. EPS estimate also fell from CN¥2.01 per share to CN¥1.34 per share. Net income forecast to grow 17% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target down from CN¥29.11 to CN¥27.81. Share price fell 5.3% to CN¥17.28 over the past week. New Risk • Oct 24
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 18% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). High level of non-cash earnings (22% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows. New Risk • Aug 19
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 20% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows. Reported Earnings • Aug 18
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2023 results: EPS: CN¥0.58 (down from CN¥0.68 in 2Q 2022). Revenue: CN¥8.12b (up 55% from 2Q 2022). Net income: CN¥973.4m (down 14% from 2Q 2022). Profit margin: 12% (down from 22% in 2Q 2022). Revenue exceeded analyst estimates by 37%. Earnings per share (EPS) missed analyst estimates by 7.9%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Ankündigung • Jul 01
Sinoma Science & Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 18, 2023 Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 18, 2023 Ankündigung • May 25
Sinoma Science & Technology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 31, 2023 Sinoma Science & Technology Co.,Ltd. announced final cash dividend/10 shares (tax included) of CNY 6.60000000 on A shares for the year 2022. Record date is May 30, 2023. Ex-date is May 31, 2023. Payment date is May 31, 2023. Valuation Update With 7 Day Price Move • Apr 26
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥20.07, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 78% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥8.97 per share. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥24.89, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 130% over the past three years. Price Target Changed • Mar 18
Price target decreased by 7.6% to CN¥30.24 Down from CN¥32.73, the current price target is an average from 4 analysts. New target price is 41% above last closing price of CN¥21.43. Stock is down 15% over the past year. The company is forecast to post earnings per share of CN¥2.12 for next year compared to CN¥2.09 last year. 
